MAP2 Antibody
Catalog Number: LS-C204536-50
50 µL / $426.00
Antibody: Chicken Polyclonal
Applications: Immunocytochemistry, Immunofluorescence, Western Blot
Reactivity: Human
Format: Liquid
Anti-MAP2 antibody IHC of human brain, cortex. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 5 ug/ml.
PathPlus™ MAP2 Antibody (C-Terminus)
Primary AntibodyLSBio Guarantee
| Antibody: | Chicken Polyclonal |
| Applications: | Immunohistochemistry (general), Immunohistochemistry, Paraffin |
| Reactivity: | Bovine, Human, Mouse, Rat |
| Format: | Liquid |
$383.00each
Catalog Number: LS-B290-0.05
Catalog Number: LS-B290
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- MAP2 antibody LS-B290 is an unconjugated chicken polyclonal antibody to MAP2 (C-Terminus) from human. It is reactive with human, mouse, rat and other species. Validated for IHC. Cited in 8 publications.
- Application
- IHC, IHC-P
- Reactivity
- Bov, Hu, Ms, Rt
- Intended Use
- RUO
- Guarantees
- This product carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- MAP2C | MAP-2 | MAP2 | MAP2A | MAP2B
- Recommended Dilution: IHC-P
- 5 µg/ml
- UniProt Number
- P11137
- NCBI GenBank
- NM_002374, NP_002365.3
- SwissProt
- P11137
Target
- Target
- MAP2
- Antigen Species
- Hu
- Specificity
- C-terminus of human, mouse, rat, bovine MAP2, a neuronal dendrite marker
- Gene Name
- MAP2
Antibody
- Host Species
- Ck
- Clonality
- Polyclonal
- Origin Species
- Hu
Immunogen
- Immunogen
- Synthetic peptide from C-Terminus of human MAP2
Format
- Conjugate/Label
- Unconj
- Format
- Liquid
- Formulation
- PBS, 0.02% Sodium Azide
- Volume
- 0.05 Milliliter
- Animal Free
- No
- Carrier-Free
- Yes
- Preservative
- Yes
- Purification Method
- AS Ppt
Storage & Handling
- Storage Conditions
- Short term: store at 4°C. Long term: store at -20°C. Avoid freeze-thaw cycles.
- Recommended Storage Buffer
- PBS
Activity-dependent dendritic spine shrinkage and growth involve downregulation of cofilin via distinct mechanisms. Calabrese B, Saffin JM, Halpain S. PloS one. 2014;9:e94787. PubMed: 24740405 PMC: PMC3989342
